(MENAFN- EIN Presswire)
Emergen Research Logo
The DNA Testing market is expected to grow from an estimated USD 12.51 billion in 2024 to USD 81.82 billion in 2033, at a CAGR of 23.20%.
VANCOUVER, BRITISH COLUMBIA, CANADA, February 3, 2025 /EINPresswire / -- The global DNA testing market is projected to grow from an estimated USD 12.51 billion in 2024 to USD 81.82 billion by 2033, at a compound annual growth rate (CAGR) of 23.20%. This growth is being fueled by the increasing demand for personalized medicine, advancements in genetic testing techniques, and a rising consumer awareness of the benefits of genetic testing for disease prevention and early detection.
Get Free Sample PDF Copy Of This Report@
Market Drivers:
The main driver of the DNA testing market is the ongoing advancements in genetic testing technologies. Next-generation sequencing (NGS) and chromosomal microarray analysis have revolutionized the detection of genetic disorders by allowing for a more accurate understanding of structural and numerical abnormalities in chromosomes. These technologies are also key to the development of non-invasive prenatal tests and carrier screening tests, allowing for the detection of a wide range of genetic conditions.
Major players in the industry are actively investing in the development of innovative genetic testing products. For instance, Myriad Genetics introduced AMPLIFY technology to enhance its noninvasive prenatal screening (NIPS) tests, while Roche introduced FoundationOne Liquid, a blood-based genetic profile test. These new products are expected to continue driving market growth.
Moreover, the rising interest in personalized medicine is a significant factor driving the demand for genetic testing. Pharmacogenomics, or drug-gene testing, is helping to develop customized drug treatments based on an individual's genetic makeup, speeding up drug discovery processes and improving patient outcomes.
Market Restraints:
Despite the promising growth, the DNA testing market faces some challenges, particularly around data privacy concerns. The use of genetic data raises concerns over patient privacy, as individuals may lose control over their genetic information when undergoing genetic testing. This issue has become a significant barrier to widespread adoption, especially in regions like the United States, where concerns over data security and privacy laws could limit the market's growth.
Browse Full Report:
Segments Insights:
The DNA testing market is categorized by various technologies, with next-generation sequencing (NGS) leading the market in 2023. NGS is critical for genome mapping and is increasingly used to detect and examine various cancers and genetic disorders, contributing to the growth of the market. The technology's ability to provide detailed genetic information makes it an essential tool in both clinical and research settings.
The array technology segment, which includes DNA-based arrays used for genetic disorder diagnosis, is expected to grow at a significant rate. These arrays are especially useful in drug development, gene expression research, and early-stage cancer detection, further fueling their increasing adoption.
Some of the key companies in the global DNA Testing Market include:
24 genetics
Circle DNA
Tellmegen
23andme
AncestryDNA
MyDNA
Everly Well
Igenomix
VitaGen
Myriad Genetics, Inc.
Mapmygenome
DNA Testing Latest Industry Updates
In November 2024, DNA Complete, Inc., a fully owned subsidiary of ProPhase Labs, Inc., has been established to provide D2C DNA testing.
In November 2024, Myriad Genetics, Inc. introduced SneakPeek, a gender test that can be taken at home and is sold at 8,800 stores nationwide.
Request For Discount:
DNA Testing Market Segmentation Analysis
By Technology Outlook (Revenue, USD Billion; 2020-2033)
Next Generation Sequencing
Array Technology
PCR-based Testing
FISH
Others
By Application Outlook (Revenue, USD Billion; 2020-2033)
Ancestry & Ethnicity
Traits Screening
Genetic Disease Carrier Status
New Baby Screening
Health and Wellness-Predisposition/Risk/Tendency
By Product Outlook (Revenue, USD Billion; 2020-2033)
Consumables
Equipment
Software & Services
By Channel Outlook (Revenue, USD Billion; 2020-2033)
Online
Offline
By End-Use Outlook (Revenue, USD Billion; 2020-2033)
Hospitals & Clinics
Diagnostic Laboratories
Others
By Regional Outlook (Revenue, USD Billion; 2020-2033)
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Benelux
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Buy Now:
Eric Lee
Emergen Research
+ +91 90210 91709
...
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN03022025003118003196ID1109160822
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.